Logo image of DX

DYNEX CAPITAL INC (DX) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:DX - US26817Q8868 - REIT

13.83 USD
+0.08 (+0.58%)
Last: 12/19/2025, 8:04:00 PM
13.92 USD
+0.09 (+0.65%)
After Hours: 12/19/2025, 8:04:00 PM
Fundamental Rating

5

DX gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 68 industry peers in the Mortgage Real Estate Investment Trusts (REITs)" industry. While DX is still in line with the averages on profitability rating, there are concerns on its financial health. DX is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

DX had positive earnings in the past year.
DX had a positive operating cash flow in the past year.
DX had positive earnings in 4 of the past 5 years.
In the past 5 years DX always reported a positive cash flow from operatings.
DX Yearly Net Income VS EBIT VS OCF VS FCFDX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

DX's Return On Assets of 1.24% is amongst the best of the industry. DX outperforms 86.76% of its industry peers.
Looking at the Return On Equity, with a value of 8.96%, DX belongs to the top of the industry, outperforming 92.65% of the companies in the same industry.
DX's Return On Invested Capital of 0.18% is on the low side compared to the rest of the industry. DX is outperformed by 72.06% of its industry peers.
Industry RankSector Rank
ROA 1.24%
ROE 8.96%
ROIC 0.18%
ROA(3y)1.61%
ROA(5y)2.5%
ROE(3y)7.47%
ROE(5y)11.89%
ROIC(3y)N/A
ROIC(5y)N/A
DX Yearly ROA, ROE, ROICDX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

1.3 Margins

The Profit Margin of DX (39.43%) is better than 94.12% of its industry peers.
In the last couple of years the Profit Margin of DX has declined.
The Operating Margin of DX (7.21%) is worse than 60.29% of its industry peers.
The Gross Margin of DX (17.47%) is worse than 79.41% of its industry peers.
DX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 7.21%
PM (TTM) 39.43%
GM 17.47%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-37.42%
PM growth 5YN/A
GM growth 3Y-75.33%
GM growth 5Y-47.03%
DX Yearly Profit, Operating, Gross MarginsDX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2K -2K -4K

2

2. Health

2.1 Basic Checks

DX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for DX has been increased compared to 1 year ago.
Compared to 5 years ago, DX has more shares outstanding
Compared to 1 year ago, DX has an improved debt to assets ratio.
DX Yearly Shares OutstandingDX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
DX Yearly Total Debt VS Total AssetsDX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

DX has an Altman-Z score of -0.90. This is a bad value and indicates that DX is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.90, DX is not doing good in the industry: 79.41% of the companies in the same industry are doing better.
DX has a debt to FCF ratio of 96.76. This is a negative value and a sign of low solvency as DX would need 96.76 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 96.76, DX is in the better half of the industry, outperforming 64.71% of the companies in the same industry.
DX has a Debt/Equity ratio of 6.01. This is a high value indicating a heavy dependency on external financing.
DX has a Debt to Equity ratio (6.01) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 6.01
Debt/FCF 96.76
Altman-Z -0.9
ROIC/WACC0.03
WACC5.71%
DX Yearly LT Debt VS Equity VS FCFDX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

DX has a Current Ratio of 0.05. This is a bad value and indicates that DX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of DX (0.05) is worse than 77.94% of its industry peers.
A Quick Ratio of 0.05 indicates that DX may have some problems paying its short term obligations.
DX has a Quick ratio of 0.05. This is in the lower half of the industry: DX underperforms 77.94% of its industry peers.
Industry RankSector Rank
Current Ratio 0.05
Quick Ratio 0.05
DX Yearly Current Assets VS Current LiabilitesDX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 202.63% over the past year.
DX shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -18.72% yearly.
DX shows a strong growth in Revenue. In the last year, the Revenue has grown by 47.97%.
DX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.32% yearly.
EPS 1Y (TTM)202.63%
EPS 3Y-18.72%
EPS 5YN/A
EPS Q2Q%350%
Revenue 1Y (TTM)47.97%
Revenue growth 3Y68.26%
Revenue growth 5Y13.32%
Sales Q2Q%3324.05%

3.2 Future

Based on estimates for the next years, DX will show a very strong growth in Earnings Per Share. The EPS will grow by 70.62% on average per year.
Based on estimates for the next years, DX will show a very strong growth in Revenue. The Revenue will grow by 159.76% on average per year.
EPS Next Y336.04%
EPS Next 2Y134.28%
EPS Next 3Y70.62%
EPS Next 5YN/A
Revenue Next Year741.85%
Revenue Next 2Y343.97%
Revenue Next 3Y159.76%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
DX Yearly Revenue VS EstimatesDX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 100M 200M 300M
DX Yearly EPS VS EstimatesDX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2 3

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 17.73, DX is valued on the expensive side.
DX's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of DX to the average of the S&P500 Index (26.38), we can say DX is valued slightly cheaper.
A Price/Forward Earnings ratio of 9.44 indicates a reasonable valuation of DX.
Based on the Price/Forward Earnings ratio, DX is valued a bit cheaper than the industry average as 63.24% of the companies are valued more expensively.
DX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.83.
Industry RankSector Rank
PE 17.73
Fwd PE 9.44
DX Price Earnings VS Forward Price EarningsDX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

DX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. DX is cheaper than 88.24% of the companies in the same industry.
60.29% of the companies in the same industry are more expensive than DX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 16.69
EV/EBITDA 45.6
DX Per share dataDX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
DX's earnings are expected to grow with 70.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.05
PEG (5Y)N/A
EPS Next 2Y134.28%
EPS Next 3Y70.62%

5

5. Dividend

5.1 Amount

DX has a Yearly Dividend Yield of 14.84%, which is a nice return.
Compared to an average industry Dividend Yield of 12.56, DX pays a better dividend. On top of this DX pays more dividend than 83.82% of the companies listed in the same industry.
DX's Dividend Yield is rather good when compared to the S&P500 average which is at 1.87.
Industry RankSector Rank
Dividend Yield 14.84%

5.2 History

The dividend of DX decreases each year by -11.72%.
DX has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-11.72%
Div Incr Years0
Div Non Decr Years0
DX Yearly Dividends per shareDX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6 8

5.3 Sustainability

115.43% of the earnings are spent on dividend by DX. This is not a sustainable payout ratio.
DP115.43%
EPS Next 2Y134.28%
EPS Next 3Y70.62%
DX Yearly Income VS Free CF VS DividendDX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M
DX Dividend Payout.DX Dividend Payout, showing the Payout Ratio.DX Dividend Payout.PayoutRetained Earnings

DYNEX CAPITAL INC

NYSE:DX (12/19/2025, 8:04:00 PM)

After market: 13.92 +0.09 (+0.65%)

13.83

+0.08 (+0.58%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryMortgage Real Estate Investment Trusts (REITs)"
Earnings (Last)10-20 2025-10-20/bmo
Earnings (Next)01-26 2026-01-26/bmo
Inst Owners45.47%
Inst Owner Change-13.59%
Ins Owners0.75%
Ins Owner Change-0.84%
Market Cap2.03B
Revenue(TTM)444.98M
Net Income(TTM)175.44M
Analysts82.86
Price Target14.64 (5.86%)
Short Float %6.47%
Short Ratio2.01
Dividend
Industry RankSector Rank
Dividend Yield 14.84%
Yearly Dividend1.67
Dividend Growth(5Y)-11.72%
DP115.43%
Div Incr Years0
Div Non Decr Years0
Ex-Date01-02 2026-01-02 (0.17)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-26.74%
Min EPS beat(2)-31.42%
Max EPS beat(2)-22.06%
EPS beat(4)1
Avg EPS beat(4)-5.99%
Min EPS beat(4)-31.42%
Max EPS beat(4)42.78%
EPS beat(8)2
Avg EPS beat(8)-60.82%
EPS beat(12)2
Avg EPS beat(12)-165.76%
EPS beat(16)2
Avg EPS beat(16)-127.07%
Revenue beat(2)0
Avg Revenue beat(2)-1.86%
Min Revenue beat(2)-2.1%
Max Revenue beat(2)-1.62%
Revenue beat(4)0
Avg Revenue beat(4)-20%
Min Revenue beat(4)-51.61%
Max Revenue beat(4)-1.62%
Revenue beat(8)2
Avg Revenue beat(8)-94.47%
Revenue beat(12)4
Avg Revenue beat(12)-52.53%
Revenue beat(16)5
Avg Revenue beat(16)-38.93%
PT rev (1m)0.41%
PT rev (3m)3.11%
EPS NQ rev (1m)-11.51%
EPS NQ rev (3m)-9.56%
EPS NY rev (1m)-5.17%
EPS NY rev (3m)-12.9%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)50.58%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.81%
Valuation
Industry RankSector Rank
PE 17.73
Fwd PE 9.44
P/S 4.56
P/FCF 16.69
P/OCF 16.69
P/B 1.04
P/tB 1.04
EV/EBITDA 45.6
EPS(TTM)0.78
EY5.64%
EPS(NY)1.47
Fwd EY10.59%
FCF(TTM)0.83
FCFY5.99%
OCF(TTM)0.83
OCFY5.99%
SpS3.03
BVpS13.33
TBVpS13.33
PEG (NY)0.05
PEG (5Y)N/A
Graham Number15.3
Profitability
Industry RankSector Rank
ROA 1.24%
ROE 8.96%
ROCE 1.61%
ROIC 0.18%
ROICexc 0.19%
ROICexgc 0.19%
OM 7.21%
PM (TTM) 39.43%
GM 17.47%
FCFM 27.34%
ROA(3y)1.61%
ROA(5y)2.5%
ROE(3y)7.47%
ROE(5y)11.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-37.42%
PM growth 5YN/A
GM growth 3Y-75.33%
GM growth 5Y-47.03%
F-Score4
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 6.01
Debt/FCF 96.76
Debt/EBITDA 344.52
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 0.11
Cash Conversion 356.05%
Profit Quality 69.35%
Current Ratio 0.05
Quick Ratio 0.05
Altman-Z -0.9
F-Score4
WACC5.71%
ROIC/WACC0.03
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)202.63%
EPS 3Y-18.72%
EPS 5YN/A
EPS Q2Q%350%
EPS Next Y336.04%
EPS Next 2Y134.28%
EPS Next 3Y70.62%
EPS Next 5YN/A
Revenue 1Y (TTM)47.97%
Revenue growth 3Y68.26%
Revenue growth 5Y13.32%
Sales Q2Q%3324.05%
Revenue Next Year741.85%
Revenue Next 2Y343.97%
Revenue Next 3Y159.76%
Revenue Next 5YN/A
EBIT growth 1Y178.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y60.71%
FCF growth 3Y-53.91%
FCF growth 5Y-39.34%
OCF growth 1Y60.71%
OCF growth 3Y-53.91%
OCF growth 5Y-39.34%

DYNEX CAPITAL INC / DX FAQ

What is the ChartMill fundamental rating of DYNEX CAPITAL INC (DX) stock?

ChartMill assigns a fundamental rating of 5 / 10 to DX.


What is the valuation status of DYNEX CAPITAL INC (DX) stock?

ChartMill assigns a valuation rating of 6 / 10 to DYNEX CAPITAL INC (DX). This can be considered as Fairly Valued.


What is the profitability of DX stock?

DYNEX CAPITAL INC (DX) has a profitability rating of 4 / 10.


How financially healthy is DYNEX CAPITAL INC?

The financial health rating of DYNEX CAPITAL INC (DX) is 2 / 10.


Can you provide the dividend sustainability for DX stock?

The dividend rating of DYNEX CAPITAL INC (DX) is 5 / 10 and the dividend payout ratio is 115.43%.